Notes
National Health Service
2014 British pounds
Reference
Rinciog C, et al. A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK. PharmacoEconomics : 31 Dec 2016. Available from: URL: http://dx.doi.org/10.1007/s40273-016-0480-2
Rights and permissions
About this article
Cite this article
Nintedanib more cost effective than pirfenidone for IPF?. PharmacoEcon Outcomes News 771, 20 (2017). https://doi.org/10.1007/s40274-017-3731-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3731-3